We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Exit Notice

You are about to leave ClinicalTrials.gov and go to: Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study URL: https://doi.org/10.1182/blood-2019-132490

Click on the link to continue or return to ClinicalTrials.gov Home